|
COX4NB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.02640000229937E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.99920000010634E-07 |
| Normal-vs-Stage2 |
1.186100E-02 |
| Normal-vs-Stage3 |
1.317770E-03 |
| Normal-vs-Stage4 |
4.146000E-01 |
| Stage1-vs-Stage2 |
8.327200E-01 |
| Stage1-vs-Stage3 |
4.126000E-01 |
| Stage1-vs-Stage4 |
3.424000E-01 |
| Stage2-vs-Stage3 |
4.592000E-01 |
| Stage2-vs-Stage4 |
4.965000E-01 |
| Stage3-vs-Stage4 |
2.481800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.31519999732899E-08 |
| Normal-vs-AfricanAmerican |
2.826700E-04 |
| Normal-vs-Asian |
5.308000E-01 |
| Caucasian-vs-AfricanAmerican |
6.426400E-01 |
| Caucasian-vs-Asian |
4.611200E-01 |
| AfricanAmerican-vs-Asian |
5.803400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.27660000015517E-07 |
| Normal-vs-Female |
1.67556999999263E-05 |
| Male-vs-Female |
8.187800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.332400E-02 |
| Normal-vs-Extreme_Weight |
1.57970000003171E-06 |
| Normal-vs-Obese |
1.1783000000154E-06 |
| Normal-vs-Extreme_Obese |
3.215600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.685900E-02 |
| Normal_Weight-vs-Obese |
5.090100E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.454000E-01 |
| Extreme_Weight-vs-Obese |
6.348200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.839400E-01 |
| Obese-vs-Extreme_Obese |
2.808600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.138200E-03 |
| Normal-vs-Age(41-60Yrs) |
8.66549999978261E-07 |
| Normal-vs-Age(61-80Yrs) |
4.0395000000526E-07 |
| Normal-vs-Age(81-100Yrs) |
6.826400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.489200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.837800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.070300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.895800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.298400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.571900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.87869999743884E-10 |
| Normal-VS-Type2 PRCC |
4.022400E-02 |
| Normal-VS-KIRP CIMP |
1.655410E-01 |
| Normal-VS-Unclassified PRCC |
3.93130000000408E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.716150E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.196000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.195400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.794600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.288150E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.401200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.405630E-02 |
| Normal-vs-N1 |
2.013500E-02 |
| Normal-vs-N2 |
3.305200E-01 |
| N0-vs-N1 |
6.970800E-01 |
| N0-vs-N2 |
2.264800E-01 |
| N1-vs-N2 |
1.467170E-01 |
|
|
